Matches 1 - 50 out of 116 1 2 3 >


Match Document Document Title
US20110224245 Treatment Of Neurological Disorders Using Huperzine  
Methods and compositions containing huperzine for direct delivery to central nervous system (CNS) tissue are used to alleviate pain and for the prevention and/or treatment of seizures and...
US20130040982 ORAL SUSTAINED RELEASE FORMULATION OF HUPERZINE A  
Sustained-release formulations comprising huperzine A are disclosed herein. The formulations are for oral administration, and contain a carrier which comprises native albumin. Unit dosage forms of...
US20110150766 Transdermal patch with fatal overdose protection  
A transdermal patch having a top region containing an antagonist followed by a bottom region containing an agonist, whereby the bottommost end of the bottom region is secured to the skin of the...
US20140234443 5-HT3 RECEPTOR MODULATORS, METHODS OF MAKING, AND USE THEREOF  
Novel 5-HT3 receptor modulators are disclosed. These compounds are used in the treatment of various disorders, including chemotherapy-induced nausea and vomiting, post-operative nausea and...
US20130142845 USE OF A COMBINATION OF AN OPIOID AGONIST AND AN OPIOID ANTAGONIST FOR THE TREATMENT OF CROHN'S DISEASE AND THE SYMPTOMS ASSOCIATED WITH CROHN'S DISEASE  
The present invention is concerned with the use of combinations of opioid agonists and antagonists for treating Crohn's disease.
US20110142939 Use of a Combination of an Opioid Agonist and an Opioid Antagonist for the Treatment of Crohn's Disease and the Symptoms Associated with Crohn's Disease  
The present invention is concerned with the use of combinations of opioid agonists and antagonists for treating Crohn's disease.
US20090060871 ADMINISTRATION OF AGONIST-ANTAGONIST IN OPIOID-DEPENDENT PATIENTS  
A method for reducing psychological opioid dependence includes selecting a patient addicted to an opioid and administering to the patient an opioid agonist-antagonist for at least 14 days, thereby...
US20120107392 USE OF HUPERZINE FOR DISORDERS  
Methods and compositions containing huperzine are used to prevent and alleviate seizures. The invention is also directed to methods and compositions for using huperzine for the prevention and/or...
US20110098265 METHODS FOR REDUCING CRAVINGS AND IMPULSES ASSOCIATED WITH ADDICTIVE AND COMPULSIVE BEHAVIORS  
This document provides methods and materials related to managing weight, supporting appetite control, and controlling cravings associated with smoking reduction or cessation regimens and/or...
US20060211721 Nutraceutical formulation of a cognitive enhancement system  
A nutraceutical composition and method of use thereof includes core ingredients, huperzine A, dimethylaminoethanol (DMAE), thiamin, niacin, and pantothenic acid. The core ingredients provide a...
US20150072971 Methods for Treating Depressive Symptoms  
The present application relates methods for treating a depressive symptom comprising administering an effective amount of a μ opioid receptor agonist or a pharmaceutically acceptable salt thereof...
US20110014258 GRADIENT COATING FOR BIOMEDICAL APPLICATIONS  
The present invention provides a coating comprising a bioactive material and an antimicrobial agent, wherein the concentration of said antimicrobial agent varies throughout the thickness of the...
US20110230473 Methods and Compositions for Treating Status Epilepticus and Seizures Causing Status Epilepticus  
Disclosed herein are methods, kits and compositions for treating, preventing, inhibiting, or reducing a seizure, status epilepticus, neuropathogenesis or a neuropathology caused by overstimulation...
US20150140133 IN SITU CONTROLLED RELEASE DRUG DELIVERY SYSTEM  
A system is described for long-term controlled release delivery of a drug or a therapeutic agent. According to the invention, one or more drugs or therapeutic agents contained in microspheres are...
US20150045384 Morphan and Morphinan Analogues, and Methods of Use  
The present application relates to analogues of morphan and morphinan, compositions thereof, and methods for treating a disease or condition comprising administering an effective amount of the...
US20080090859 Use of Selective Opiate Receptor Modulators In the Treatment Of Neuropathy  
The instant invention relates to the use of compounds that are effective as selective opiate receptor modulators for the manufacture of a pharmaceutical for the diagnosis, prophylaxis and/or the...
US20110092464 NEUROGENESIS BY MODULATING ANGIOTENSIN  
The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The invention includes...
US20110059905 METHODS OF TREATING DISEASE-INDUCED ATAXIA AND NON-ATAXIC IMBALANCE  
Methods for treatment of disease-induced ataxia and non-ataxic imbalance are disclosed. The methods involve treating a patient with a compound having nicotinic acetylcholine receptor activity.
US20130289021 PHARMACEUTICAL COMPOSITIONS AND METHODS FOR PREVENTING, TREATING, OR REVERSING NEURONAL DYSFUNCTION  
The present invention provides compositions and methods for preventing, treating or reversing neuronal dysfunction in a mammal resulting from exposure to organophosphate nerve agents,...
US20110064804 Methods and Compositions for the Treatment of CNS-Related Conditions  
The present invention provides novel methods and compositions for the treatment and prevention of CNS-related conditions. One of the CNS-related conditions treated by the methods and compositions...
US20100311697 Methods and Compositions for the Treatment of CNS-Related Conditions  
The present invention provides novel methods and compositions for the treatment and prevention of CNS-related conditions. One of the CNS-related conditions treated by the methods and compositions...
US20110288101 SURGICAL COMPOSITIONS CONTAINING SIGMA-RECEPTOR AGONISTS  
One aspect of the present invention relates to aqueous surgical compositions comprising a sigma-1 receptor agonist. Another aspect of the present invention relates to methods of irrigating ocular...
US20050032806 Method for treating anhedonia using dopamine agonists  
A method of treating anhedonia in a patient in need thereof, comprising administering to the patient an effective amount of a dopamine agonist
US20100234416 USE OF HUPERZINE FOR DISORDERS  
Methods and compositions containing huperzine are used to prevent and alleviate neuropathic pain. The invention is also directed to methods and compositions for using huperzine for the prevention...
US20140274957 METHODS AND COMPOSITIONS FOR CORRECTION OF ORGAN DYSFUNCTION  
The present invention includes compositions and methods for treating certain conditions, the composition comprising a choline compound; a cholinesterase inhibitor; and Acetyl-L-Carnitine, wherein...
US20050171139 Treating psychotic symptoms  
The invention provides compositions and methods for treating a human diagnosed as having, or at risk for developing, a psychotic symptom by administering a full agonist of a dopamine D2-like...
US20070110715 Treatment of alzheimer's disease  
The present invention. The invention relates to the use of interferon-β (IFN-β) for treating and/or preventing Alzheimer's disease (AD), Creutzfeld-Jakob disease (CJD) or...
US20150150819 COMPOSITIONS CONTAINING OPIOID ANTAGONISTS  
Compositions containing opioid antagonists are disclosed, particularly alvimopan and its active metabolite in solid dosage forms, where the drug is uniformly distributed, achieves the desired...
US20080306019 Dopamine Receptor Agonists in the Treatment and Prevention of Hiv-Induced Dementia  
Provided herein is a method of protecting a neuron from dysfunction induced by an HIV neurotoxin, comprising contacting the cell with a therapeutically effective dose of a dopamine D1 receptor...
US20060210546 Athlete dietary supplement  
A vitamin supplement to temporarily enhance the abilities of a individual during a sport activity which includes a plurality of B family vitamins and one or more other vitamins, minerals, and/or...
US20060264454 Use of huperzine for neuropathic pain  
Methods and compositions containing huperzine are used to prevent and alleviate neuropathic pain. The invention is also directed to methods and compositions for using huperzine for the prevention...
US20100172974 MELT-EXTRUDED ORALLY ADMINISTRABLE OPIOID FORMULATIONS  
Bioavailable sustained release oral opioid analgesic dosage forms, comprising a plurality of multiparticulates produced via melt extrusion techniques are disclosed.
US20060089373 High potency dopaminergic treatment of neurological impairment associated with brain injury  
Methods and compositions are described for treating impaired neurological function, including altered state of consciousness disorders, in an individual who has sustained a brain injury comprising...
US20150182550 INHIBITORS OF THE INTERACTION OF THE SIGMA-1 RECEPTOR WITH hERG FOR USE IN THE TREATMENT OF CANCER  
A method of treating cancer is described. The method includes administering to a person in need thereof an effective amount of a ligand selected from the group consisting of shRNA, igmesine, and...
US20080226759 SYSTEM FOR TREATING ADDICTIONS  
A system for treating addictions includes genetic testing to determine the presence of allelic variants of genes shown to be associated with impulsive/addictive behaviors and a tailored...
US20070071818 EFFERVESCENT FORMULATIONS COMPRISING APOMORPHINE  
An effervescent formulation comprising apomorphine, preferably comprising multilayer effervescent microspheres containing an acidic substance, a basic substance and water-soluble isolating agent....
US20080312189 Cadasil Treatment with Cholinesterase Inhibitors  
The invention provides methods for treating and/or preventing cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) in a patient in need thereof by...
US20110275616 Combination Analgesic Employing Opioid and Neutral Antagonist  
Methods of utilizing an opioid agonist in a mammalian subject in a manner that inhibits peripheral effects of the opioid agonist are described. The methods comprise administering the opioid...
US20050002992 Foods, beverages, condiments, spices and salad dressings with specialized supplements  
A food, beverage, condiment, spice or salad dressing designed to enhance the human metabolism includes a food, beverage, condiment, spice, or salad dressing base and a weight loss supplement,...
US20080009467 COMBINATIONS OF MEDIUM CHAIN TRIGLYCERIDES AND THERAPEUTIC AGENTS FOR THE TREATMENT AND PREVENTION OF ALZHEIMERS DISEASE AND OTHER DISEASES RESULTING FROM REDUCED NEURONAL METABOLISM  
Methods and compositions for treating or preventing, the occurrence of senile dementia of the Alzheimer's type, mild cognitive impairment, or other conditions arising from reduced neuronal...
US20120302591 METHODS OF USING 8-CARBOXAMIDO-2,6-METHANO-3-BENZAZOCINES  
8-Substituted-2,6-methano-3-benzazocines of general structure I in which A is —CH2—OH, —CH2NH2, —NHSO2CH3, and Y is O, S or NOH are useful as analgesics, anti-diarrheal agents, anticonvulsants,...
US20050215571 Therapeutic combination for cognititon enhancement and psychotic disorders  
This invention relates to combinations of an atypical antipsychotic, and a nicotinic receptor agonist or antagonist, kits containing such combinations, pharmaceutical compositions comprising such...
US20100240690 COMPOSITIONS CONTAINING OPIOID ANTAGONISTS  
Compositions containing opioid antagonists, particularly alvimopan and its active metabolite, with improved solubility and bioavailability for oral or parenteral administration, injectable dosage...
US20100291203 Opioid Agonist/Antagonist Combinations  
The invention is directed in part to oral dosage forms comprising a combination of an orally analgesically effective amount of an opioid agonist and an orally active opioid antagonist, the opioid...
US20110237618 METHODS FOR TREATING MIGRAINES WITH HUPERZINE A DERIVATIVES  
The present invention relates to a method for treating, alleviating, or preventing pain, particularly migraines, functional pain syndrome, or organic pain syndrome, by administering to a patient...
US20060178394 Pharmaceutical compositions comprising apomorphine for pulmonary inhalation  
The present invention relates to inhalable formulations of apomorphine or its pharmaceutically acceptable salts or esters for use in treating sexual dysfunction. The present invention also relates...
US20150072006 Pharmaceutical Formulations  
The invention relates to drug preparations with controlled active ingredient released in the form of microtablets which contain, as active ingredient, flupirtin or one of its physiologically...
US20070203176 Crystalline forms of dolasetron base and processes for preparation thereof  
The present invention provides crystalline polymorphic forms of Dolasetron base. Also provided are methods of preparing the crystalline polymorphic forms of Dolasetron base.
US20120164191 TRANSMUCOSAL DELIVERY DEVICES WITH ENHANCED UPTAKE  
The present invention provides methods for enhancing transmucosal uptake of a medicament, e.g., fentanyl or buprenorphine, to a subject and related devices. The method includes administering to a...
US20090047234 Compositions for nasal delivery  
The present invention concerns a method of administering at least one active pharmaceutical agent to a patient in need thereof, which method comprises the intranasal administration of a...

Matches 1 - 50 out of 116 1 2 3 >